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DimerCiliary neurotrophic factor (CNTF) signals via a receptor complex consisting of the speciﬁc CNTF receptor
(CNTFR) and two promiscuous signal transducers, gp130 and leukemia inhibitory factor receptor (LIFR).
Whereas earlier studies suggested that the signaling complex is a hexamer, more recent analyses strongly
support a tetrameric structure. However, all studies so far analyzed the stoichiometry of the CNTF receptor
complex in vitro and not in the context of living cells. We generated and expressed in mammalian cells acyl
carrier protein-tagged versions of both CNTF and CNTFR. After labeling CNTF and CNTFR with different dyes
we analyzed their diffusion behavior at the cell surface. Fluorescence (cross) correlation spectroscopy (FCS/
FCCS) measurements reveal that CNTFR diffuses with a diffusion constant of about 2×10−9 cm2 s−1
independent of whether CNTF is bound or not. FCS and FCCS measurements detect the formation of receptor
complexes containing at least two CNTFs and CNTFRs. In addition, we measured Förster-type ﬂuorescence
resonance energy transfer between two differently labeled CNTFs within a receptor complex indicating a
distance of 5–7 nm between the two. These ﬁndings are not consistent with a tetrameric structure of the
CNTFR complex suggesting that either hexamers and or even higher-order structures (e.g. an octamer
containing two tetramers) are formed.© 2009 Elsevier B.V. All rights reserved.1. IntroductionCiliary neurotrophic factor (CNTF) is a four-α-helical bundle helix
cytokine that belongs to the interleukin-6 (IL-6) type cytokine family
which uses the common signal transducer gp130 for activation of the
janus kinase/signal transducer and activator of transcription (Jak/
STAT) pathway [1,2]. CNTF is released by injured neuronal cells and
stimulates the survival and differentiation of central and peripheral
neurons [3]. In addition, CNTF also acts on hepatocytes and muscle
cells. Recently, CNTF was found to exhibit leptin-like effects on the
satiety center and to act on adipocytes suggesting that it is also
involved in the regulation of energy homeostasis [4,5]. To exert its
biological functions, CNTF ﬁrst binds its non-signaling, speciﬁc
receptor, CNTFR. Signaling through the Jak/STAT pathway follows
the recruitment of gp130 and the leukemia inhibitory factor receptor
(LIFR) into the complex. All three, CNTFR, gp130 and LIFR belong to
the hematopoietic cytokine receptor family that is characterized by a
typical cytokine-binding module in the extracellular domain [2]. The
CNTFR, however, is unique in this family since it is the only known: +49 711 45924205.
e).
ll rights reserved.receptor that does not contain a transmembrane and cytosolic domain
but is linked to the plasma membrane via a glycosyl–phosphatidyl–
inositol (GPI) anchor [6]. This lipid anchor directs the CNTFR to
detergent-resistant membrane domains and to the apical plasma
membrane of polarized epithelial cells [7].
Two models for the active receptor complex are currently
discussed: a hexameric complex in which two CNTF/CNTFR dimers
recruit one gp130 and one LIFR molecule each and a tetrameric
complex in which only one CNTF/CNTFR dimer associates with one
gp130 and one LIFR [8,9]. Many early studies promoted the hexameric
model. Thus, Paonessa et al. by using co-immunoprecipitation
protocols and tagged cytokine and receptor variants provided
evidence that two CNTF molecules and two CNTFRs are present in a
receptor complex [10,11]. The study of Man et al. showing that the C-
terminal Fibronectin type III module of the CNTFR can interact with
the cytokine-binding domain of either gp130 or LIFR in the absence of
a ligand also was more consistent with the hexameric model [12]. The
hexameric nature of the CNTFR complex was further implicated by
structural studies of the Garcia group showing that the related
interleukin-6 receptor complex also has a hexameric architecture (2×
IL-6/IL-6R, 2× gp130) [13]. In contrast, in a recently published study
the same group provided strong evidence for the tetrameric nature of
the CNTFR complex using a very similar approach, i.e. thermodynamic
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cular modeling [14].
The limitation of all these studies is that the receptor formation
was studied by in vitro assays using puriﬁed cytokine and receptor
components, i.e. without possible contributions from the cellular
membrane. In order to study the receptor stoichiometry in a more
physiological environment, we set out to generate variants of CNTF
and the CNTFR which can be labeled post-synthetically with different
stable ﬂuorescent dyes [15,16]. Instead of using classical derivatives of
the green ﬂuorescent protein we took advantage from this recently
developed technique by which generated fusion proteins with an acyl
carrier protein (ACP) tag are labeled in an enzymatic reaction. Thus,
several available small ﬂuorophores coupled to Coenzym A (CoA) can
be covalently linked to the ACP-tagged protein of interest [17]. This
approach comes up with four major advantages: i) proteins can be
labeled post-synthetically with the ﬂuorophores; ii) exclusively
proteins on the cell surface are labeled; iii) due to the variable choice
of several ﬂuorophores with different spectral characteristics an
optimal set of ﬂuorescent pairs is achieved, i.e. to be analyzed by
Förster-type ﬂuorescence resonance energy transfer (FRET) or
ﬂuorescence cross correlation spectroscopy (FCCS) [18,19]; iv) equal
molar amounts of two different ﬂuorophores can be applied under
controlled conditions. With the help of these tools we studied the
interaction of CNTF and its receptor in living cells on a single molecule
base using ﬂuorescence correlation spectroscopy (FCS), FCCS and
FRET, and we provide evidence that receptor complexes, which
contain more than one CNTF and CNTFR each, can form.
2. Materials and methods
2.1. Expression vectors
To construct human CNTF with an N-terminally added acyl carrier
protein (ACP)-tag, the vectors pRSET-hCNTF [20] and pSEMXT-ACP-
wild-type (wt)-GPI (Covalys, Witterswil, Switzerland) were used.
First, pRSET-CNTF served as template to amplify the CNTF cDNA by
PCR as an EcoRI/ApaI fragment (forward primer: 5′-GGGAAT TCATGG
CTT TCA CAG AGC-3′; reverse primer: 5′-CCG GGC CCC TAC ATT TTC
TTG TTG TTA GC-3′) with a termination codon followed by the ApaI
site. The EcoRI/ApaI-CNTF-fragment was inserted into the EcoRI/
ApaI-digested pSEMXT-ACPwt-GPI vector. The digest removed the
GPI-cDNA resulting in the construct sigER-ACPwt-CNTF (named ACP-
CNTF) which contains an N-terminal signal sequence to direct the
protein into the secretory pathway. The construct was veriﬁed by
sequencing by GATC (Konstanz, Germany). In order to construct an
ACP-tagged human CNTFR pSVL-CNTFR [7] was used as PCR-template
and CNTFR ampliﬁed as an EcoRI/XhoI-fragment (forward primer: 5′-
CAA GAA TTC TAC GCC CAG AGA CAC AGT C-3′; reverse primer: 5′-GCC
CTC GAG TCA GAT CAA GAG ACT GTC G-3′). After EcoRI/XhoI-digest of
the PCR-product and of pSEMXT-ACPwt-GPI respectively, both
fragments were isolated and ligated resulting in the construct sigER-
ACPwt-CNTFR (named ACP-CNTFR). This construct still possesses the
CNTFR GPI anchor sequence but lacks the GPI sequence from the
pSEMXT-ACPwt-GPI vector. As controls pSVL-CNTFRwt or pCB6 vector
was used.
2.2. Cell culture and transfection
MDCK cells, strain II, were grown in Dulbecco's Modiﬁed Eagle
medium (DMEM) high glucose (4,5 g/L) with 10% fetal calf serum and
penicillin (60 mg/L)/streptomycin (100 mg/L) at 37 °C in a water-
saturated atmosphere containing 5% CO2. Transfection of MDCK cells
was performed by a modiﬁcation of the calcium–phosphate precipita-
tion procedure as described [21,22]. Cells were cotransfected with
pSEMXT-ACP-CNTFR and empty pCB6 vector containing a gene
encoding neomycin resistance which allows selection of positiveclones with the antibiotic geneticin/G418. Two days after transfection,
cells were transferred to 24-well plates and on the next day selection
was started with 1 mg/mL G418. G418-resistant MDCK cells were
subcloned and later cultivated under the selection of 0.5 mg/mL G418.
Accordingly, MDCK cells stably expressing ACP-CNTF were generated.
HeLa ATCC cells were maintained in RPMI 1640/5–10% fetal calf
serum/1% penicillin/streptomycin. HeLa cells were transfected with
Nanofectin® (PAA Laboratories, Pasching, Austria) or Effectene
(Qiagen, Hilden, Germany) for ﬂuorescence correlation spectroscopy
(FCS) and ﬂuorescence cross correlation spectroscopy (FCCS) mea-
surements according to the manufacturer's instructions. HeLa cells
were seeded in 30-mm glass bottom culture dishes (MatTek
Corporation, Ashland, USA) the day before transfection. The spectro-
scopic analyses were done 24 h after transfection. Collection of
medium containing ACP-CNTF or analysis of expression of ACP-CNTFR,
respectively, was carried out 24–48 h after transfection. Parental
MDCK cells or cells expressing CNTFRwt were used as controls.
2.3. Micro-concentration and characterization of ACP-CNTF
Conditionedmediumwas collected after 2 days from stableMDCK-
ACP-CNTF clones maintained under serum-free conditions. Accord-
ingly, medium from transiently expressing HeLa cells was collected
24 h and 48 h after transfection. ACP-CNTF-containing medium was
centrifuged, sterile-ﬁltered, and concentrated over Amicon® Ultra-15
10 kDa Centrifugal Filter Devices (Millipore, Schwalbach/T., Ger-
many). Concentration of ACP-CNTF was determined by semi-quanti-
tative Western blotting using commercial human recombinant CNTF
with deﬁned concentration as a reference (tebu-bio, Offenbach,
Germany). For this, aliquots of medium containing ACP-CNTF were
incubated with 0.015% sodium deoxycholate for 10 min and then
precipitated with 7.2% trichloroacetic acid for 20 min at 4 °C. Pellets
were washed with cold acetone and dissolved in SDS sample buffer
(Laemmli buffer).
2.4. Labeling and ﬂuorescence detection of ACP-tagged proteins
ACP-Synthase, CoA-488 (ﬂuorescence excitation maximum
λ=502 nm/emission maximum λ=522 nm), CoA-547 (excitation
λ=554 nm, emission λ=566 nm) and CoA-647 (excitation
λ=651 nm, emission λ=666 nm) were obtained from Covalys
(Witterswil, Switzerland). For control and Western blotting experi-
ments 50–150 ng ACP-CNTF (in DMEM) was labeled with varying
amounts of CoA-488 (ﬁnal concentration 1–20 μM),10 mMMgCl2 and
1 μM ACP-Synthase in DMEM or PBS++ (phosphate-buffered saline
(PBS): 2.68 mM KCl, 1.47 mM KH2PO4, 0.14 M NaCl, 8.09 mM
Na2HPO4×2 H2O, pH 7.4; additionally 1mMMgCl2 and 0.1mMCaCl2).
For FCS experiments 50 μL of concentrated ACP-CNTF (2.5 ng/mL)was
labeled with 20 μMCoA-488 or 20 μMCoA-647, 40mMMgCl2 and 5 μL
ACP-Synthase. The labeling reactions were incubated at 37 °C for
30 min. For assaying bioactivity, DMEM was added and labeled ACP-
CNTF was directly used to stimulate cells. SDS sample buffer was
added to analyze labeled ACP-CNTF by SDS-PAGE. For all other
experiments, unbound dye was removed by size exclusion chromato-
graphy using Sephadex G-25 Fine, equilibrated with PBS [23]. ACP-
CNTF was eluated by centrifugation and the concentration was
measured as described above.
To visualize CoA-488 labeled ACP-CNTF on Western blots, poly-
vinylidene ﬂuoride (PVDF) membranes were scanned with a Typhoon
scanning device (GE Healthcare, Munich, Germany) using a standard
blue laser (488 nm), ﬁlter 526SP (photomultiplier 500, pixel 50 μm)
and Image Quant TL software. After ﬂuorescence imaging, the
membrane was blocked in skimmed milk powder and CNTF detected
by Western blotting.
ACP-CNTFR expressed in HeLa cells was labeled with 5 μM CoA-
547, 10 mMMgCl2 and 1 μM ACP-Synthase for 30 min on ice. For FCS/
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calf serum containing 8 mM MgCl2, 1.32 μM CoA-488 (for FCS
measurements) or 1.32 μM CoA-488 and 1.32 μM CoA-647 (for FCCS
measurements) and 5 μL ACP-Synthase. The cells were incubated for
30 min at 37 °C in a water-saturated atmosphere. After labeling the
cells were washed three times with RPMI/5% FCS and immediately
analyzed.
2.5. Cell lysis and deglycosylation with PNGaseF
Cells grown to conﬂuency were collected in PBS containing
sodium-o-vanadate (0.1 mM), centrifuged, dissolved in hypotonic
buffer (10 mM HEPES–KOH pH 7.9, 1.5 mM MgCl2, 10 mM KCl and
proteinase inhibitors) and incubated for 20 min on ice. After the
incubation Triton X-100 (TX100) was added to a ﬁnal concentration of
1%, thoroughly mixed and centrifuged at full speed for 10 s. Samples
containing CNTFRwere centrifuged only at low speed and very shortly
since CNTFR is TX100-insoluble [7] and thus pelleted at low
temperatures. Cell lysates were precipitated with 9-fold ice-cold
acetone at −20 °C. Dried protein pellets were directly subjected to
SDS-PAGE or digested with PNGaseF.
To this end, acetone-precipitated proteins were dissolved in 1%
SDS/20 mM Tris–HCl pH 7.4 and heated for 5 min at 95 °C. After 1:5
dilution with PNGase buffer (125 mM Na2HPO4, 62 mM EDTA, 1.25%
TX100, 1% β-mercaptoethanol pH 7.5) proteins were incubated with
0.4 units PNGaseF (Sigma-Aldrich, Taufkirchen, Germany) for 20 h at
37 °C. SDS sample buffer was added and proteins were denaturated at
95 °C.
2.6. Stimulation with ACP-/CNTF
Prior to experiments, MDCK-CNTFR or transfected HeLa cells were
serum-starved overnight. Cells were incubated with 25 ng commer-
cially available CNTF or an equivalent amount of ACP-CNTF per mL
medium/0.2% BSA for 30 min at 37 °C. Cells were washed twice and
lysed in buffer containing 20 mM Tris–HCl pH 7.5, 150 mM NaCl,
10 mM NaF, 1 mM EDTA, 1% TX100 and protease inhibitors for 30 min
on ice. Lysates were centrifuged for 10 min at 4 °C and total protein in
the supernatant was determined using a detergent-compatible
protein assay. Equal amounts of protein were loaded on SDS-
polyacrylamide gels. For FCS/FCCS measurements, HeLa cells were
stimulated with 50 ng/mL unlabeled ACP-CNTF or 50 ng/mL of
labeled ACP-CNTF at 37 °C for 20 min in awater-saturated atmosphere
with 5% CO2 after which unbound ligand was removed.
2.7. SDS-PAGE, Western blotting
Proteins were separated on 10 or 12% SDS-polyacrylamide gels and
blotted onto PVDF-membranes by semi-dry Western blotting. Unspe-
ciﬁc binding was blocked with 5% skimmed milk powder in Tris-
buffered saline Tween-20 (TBST) (1.37 M NaCl, 26.82 mM KCl, 0.25 M
Tris, 0.1% Tween-20). CNTF or ACP-CNTF were detected by a rabbit
CNTF antibody (USBiological, Swampscott, MA, USA), CNTFR and ACP-
CNTFR by CNTFR-speciﬁc murine antibody clone AN-B4 (Santa Cruz
Biotechnology, Heidelberg, Germany) or clone AN-E4 (BD Pharmin-
gen, Heidelberg, Germany) respectively. Phosphorylated STAT3
(pY705-STAT3) and total STAT3 were detected with speciﬁc antibodies
(Cell Signaling Technology, Danvers, MA, USA) and appropriate
horseradish peroxidase (HRP)-conjugated secondary antibodies
using the enhanced chemiluminescence (ECL) system (Perbio Science,
Bonn, Germany). For a second detection, membranes were shortly
rinsed in methanol and incubated in Tris-buffer containing 2% SDS,
0.7% β-mercaptoethanol for 30min at 50 °C. Membranes were blocked
again in skimmed milk powder and subjected to an immunodetection
with the respective antibodies.2.8. Dual color excitation confocal microscope
Measurements were performed on a home-built confocal micro-
scope based on an Olympus IX70 microscope with a high numerical
aperture water immersion objective (Olympus UPlanApo 60×1.2).
The cell dishes were mounted on a three dimensional piezo scan stage
(P517, Physik Instrumente)with a scanning range of 200×200×20 μm3.
A home-made heating chamber surrounding the entiremicroscopewas
used to set the temperature to 37 °C.
For excitation of the dyes (CoA-488 and CoA-647) an argon–ion
laser (λ=488 nm) and a helium–neon laser (λ=632 nm) were
coupled into a single-mode glass ﬁber and directed into the confocal
microscope via a quartz plate through the optical side port of the
microscope [24]. Fluorescence of both dyes was spectrally separated
by a dichroic beam splitter (630DCXR, AHF). Fluorescence of the
sample was detected with actively quenched avalanche photo diodes
(APD) (SPCM-AQR 14, Perkin-Elmer). To decrease cellular autoﬂuor-
escence, additional bandpass ﬁlters were positioned between the
pinholes and the APDs (532/35HQ and 675/60HQ, AHF). The signals
from both APDs were multiplexed by a home-built pulse multiplier
and sent simultaneously to a single photon counting card (SPC630,
Becker&Hickl), to a hardware correlator (ALV-5000, ALV) and to a
counter card (PCI-6601, National Instruments) for data collection and
visualization.
2.9. FCS and FCCS measurements
After acquisition of a scan image of cells, the laser focus was placed
at the plasma membrane of a cell. The concentration of transiently
transfected CNTFRs had a high variance; measurements were mostly
done on cells with about 1 to 10 ﬂuorescent molecules in the focal
volume. Moderate excitation powers of 5 μW (continuous wave) for
each laser were chosen to avoid photo bleaching of dyes. Photon data
from a single focal spot were recorded for 30 min with the SPC630
card. For FCS and FCCS analysis correlation functions were calculated
from 180 s intervals to avoid inﬂuence of bleaching, ﬂuctuation of
membranes and other long term ﬂuctuations. Auto and cross
correlation curves were ﬁtted using a two dimensional diffusion
model.
2.10. FRET (Förster-type ﬂuorescence resonance energy transfer)
The positioning of the focal volume with respect to the plasma
membranewas done as described for the FCSmeasurements. For FRET
measurements only CoA-488 was directly excited with 5 μW laser
power at 488 nmwavelength. Fluorescence of both detection channels
was recorded and analyzed by home-made software [25] and by
calculating the auto correlation of the acceptor ﬂuorescence [26].
2.11. Colocalization analysis
Image analysis was performed using ImageJ (rsb.info.nih.gov/ij)
with the plugins “Colocalization Test” and “Colocalization Threshold”
by T. Collins and W. Rasband, and “Background Subtraction from
Region-of-Interest” by M. Cammer and T. Collins. Colocalization was
quantiﬁed using the thresholding algorithm of Costes et al. [27] on
background corrected images. Randomizations were done with 10
iterations (Colocalization Test plugin). If the colocalization test
resulted in no signiﬁcant difference between randomized and original
images (Pb0.95), no colocalizationwas assumed. If colocalizationwas
signiﬁcant (PN0.95), the second plugin “Colocalization Threshold”
was applied to determine colocalization parameters. Colocalization
was expressed as tM (a fraction between 0 and 1), the Manders
coefﬁcient for the respective channel calculated with the thresholding
algorithm of Costes et al. [27].
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3.1. Construction and expression of ACP-tagged CNTF and CNTFR
In order to study the stoichiometry of the CNTFR complex in living
cells ﬂuorescent correlation spectroscopy (FCS) and ﬂuorescence
cross correlation spectroscopy (FCCS) were applied to ﬂuorescently
labeled CNTF and CNTFR in living cells. For FCS and FCCS, the common
usage of ﬂuorescent proteins such as eGFP, eYFP and eCFP is
problematic due to their relative low molecular brightness and their
low photo stability. In particular, the broad ﬂuorescence spectra of
ﬂuorescent proteins lead to cross talk in FCCS measurements i.e. one
has to alternate the excitation [28]. The use of ACP-tags allows labeling
of the protein of interest with common ﬂuorophores as ﬂuorescent
labels [16]. Compared to ﬂuorescent proteins this leads to a signiﬁcant
increase of the signal-to-noise ratio and the opportunity to apply
continuous wave laser excitation for FCCS measurements. Using ACP-
tagged proteins also prevents unwanted ﬂuorescence from intracel-
lular proteins since the CoA-dyes do not penetrate the cell membrane.
Together with better ﬂuorophores the signal-to-noise ratio is further
improved.
Thus, we generated ACP-tagged versions of both CNTF and the
CNTFR. The ACP-tag was fused N-terminally to the respective protein
sequence of CNTF and CNTFR, respectively. In both cases an ER signal
sequence preceded the ACP-tag to allow for delivery of the protein to
the exocytotic pathway.
The ACP-tagged proteins were expressed transiently in HeLa cells
and stably in Madin–Darby canine kidney (MDCK) cells (Fig. 1). When
compared to commercially available CNTF (26 kDa) by SDS-PAGE
(sodium dodecylsulfate polyacrylamide gel electrophoresis) and
Western blotting the ACP-CNTF migrated considerably slower at
approximately 45 kDa (Fig. 1A). Since the ACP-tag only contributes
about 8 kDa, the difference in molecular mass of about 20 kDa cannot
be explained solely by the addition of the ACP-tag. One possible
explanation for themolecular weight difference could be that the ACP-
CNTF expressed inmammalian cells is glycosylated in contrast to CNTF
expressed in bacteria. In order to test this hypothesis, ACP-CNTF
expressed in HeLa cells and CNTF were digested with peptide-N-
glycanase F (PNGase F) and analyzed by SDS-PAGE and Western
blotting (Fig. 1A, right panel). The molecular shift of ACP-CNTF upon
PNGase F digestion clearly indicates that ACP-CNTF as secreted by
HeLa cells is glycosylated. In contrast, CNTF does not change its
mobility under these conditions. Similar results were obtained with
ACP-CNTF produced by MDCK cells (data not shown). PNGase-
digested ACP-CNTF still migrated slower than bacterially expressed
6xHis ACP-CNTF (data not shown) suggesting that the protein is
subjected to additional posttranslational modiﬁcations such as O-
glycosylation or phosphorylation. For the closely related IL-6 such
modiﬁcations have been reported [29,30]. Next we tested whether
ACP-CNTF can be labeled in vitro with ﬂuorescent dyes. As shown in
Fig. 1B, addition of increasing amounts of the ﬂuorescent label CoA-
488 to the reaction resulted in an increased ﬂuorescence of the
respective ACP-CNTF with a maximum of labeling achieved at 10–
20 μM CoA-488 as assessed by detecting directly the ﬂuorescent
signal.
Second, we analyzed the expression of the ACP-CNTFR. When
transiently expressed in HeLa cells, ACP-CNTFR migrated at around
110 kDa in contrast to authentic CNTFR which migrates at about
72 kDa (Fig. 1C) [6,7]. Again, the large molecular mass difference
suggested that in addition to the molecular mass of the ACP-tag ACP-
CNTFR also contained additional oligosaccharide chains. Digestion of
CNTFR wild-type (wt) with PNGase F resulted in a shift of the wild-
type protein from 72 kDa to approximately 60 kDa. As anticipated,
digestion of lysates of ACP-CNTFR-expressing MDCK cells resulted in a
decrease of the molecular weight of ACP-CNTFR to about 80 kDa (Fig.
1C, right), which thus migrates somewhat slower than undigestedCNTFRwt. Due to more than one start codon in the sequence of ACP-
CNTFR also CNTFR lacking the ACP-tag is produced to a certain amount
in stable MDCK cells.
Since the authentic CNTFR already contains four putative glycosy-
lation sites, all of which are used (Buk et al., unpublished data), this
suggests that the ACP sequence contributes an additional glycosyla-
tion site. Upon inspection of the ACP sequence we detected a putative
glycosylation site (Asn26-Ala-Ser).
The unexpected glycosylation of ACP-CNTF and the additional
glycosylation site in the ACP-CNTFR raised the question whether both
proteins would still be functional and capable of interacting with each
other. In order to test this, MDCK cells expressing the authentic CNTFR
were stimulatedwith comparable amounts of CNTF and ACP-CNTF and
their biological activity was assessed by measuring the phosphoryla-
tion of signal transducer and activator of transcription-3 (STAT3), a
down-stream signaling event after CNTF stimulation. Whereas in
control cells no STAT3 phosphorylation was detected, both CNTF and
ACP-CNTF stimulations resulted in a prominent activation of STAT3
(Fig.1D).When the reverse experiment was performed, stimulation of
cells expressing either authentic CNTFR or ACP-CNTFR in both cases
led to a STAT3 phospho-tyrosine signal (Fig. 1E). Both engineered
proteins combined before and after labeling with CoA-488 also
resulted in a comparable phospho-tyrosine (pY)-STAT3 signal. These
data suggested that neither the addition of the ACP-tag nor the
additional glycosylation nor the ACP-labeling reaction had a detri-
mental effect on the function of both CNTF and CNTFR. Therefore,
using these ACP-tagged molecules should allow us to monitor the
ligand–receptor interaction in living cells.3.2. Diffusion constants of CNTF and CNTFR
FCS and FCCS are powerful tools to determine diffusion constants
and concentrations of diffusing (FCS) or co-diffusing (FCCS),
ﬂuorescently labeled proteins. The required concentration of labeled
proteins for these methods is much lower than for common
techniques of classical cell biology. Firstly, we investigated the
diffusion behavior of ﬂuorescently labeled ACP-CNTF and ACP-CNTFR
via FCS. From the auto correlation function G(τ) of the ﬂuorescence
trace, we calculated concentrations from the amplitude and the
diffusion constants from the diffusion time. For the diffusion of the
cytokine ACP-CNTF measured in buffer solution a mean value of
7×10−7 cm2 s−1 was determined (Fig. 2B), which corresponds to
unhindered three dimensional diffusion [31,32]. For the ACP-CNTFR
in the plasma membrane of living HeLa cells we calculated a mean
diffusion constant of about 2×10−9 cm2 s−1 (Fig. 2A). After ACP-
CNTF was added to ACP-CNTFR expressing cells the diffusion
behavior of the receptor did not change signiﬁcantly (data not
shown). As anticipated, exogenously added labeled ACP-CNTF then
exhibited the same diffusion constant as the receptor (Fig. 2B). In
control experiments, we found that ACP-CNTF did not bind to cells
lacking CNTFR (data not shown; see also Fig. 1E). We thus concluded
that ﬂuorescent ACP-CNTF was bound speciﬁcally to its receptor. The
similar diffusion times indicated a stable complex formation of both
components.
Further analysis of the signal transducing components of the CNTF
signaling complex, namely gp130 and LIFR expressed as eGFP fusion
proteins, showed a similar diffusion constant like the CNTFR (data not
shown). Analogous to the CNTFR, gp130 and LIFR did not change their
diffusion behavior upon stimulation with CNTF.
To summarize the single-color FCS measurements, all membrane-
embedded proteins of the CNTF receptor complex (CNTFR, gp130 and
LIFR) showed the same diffusion constants independent of stimula-
tion. The cytokine CNTF exhibited free three dimensional diffusion in
aqueous solution before binding, and its mobility slowed down by two
orders of magnitude upon binding to its receptor.
Fig. 1. Expression, labeling and functionality of ACP-tagged CNTF and CNTFR. (A) Expression and de-glycosylation of ACP-CNTF. Left panel: Supernatants from stable MDCK-ACP-CNTF cells
were collected for 24–48h andconcentratedwithAmicon®Ultra-1510kDa Centrifugal FilterDevices (∼25–35-fold). Aliquots of concentratedACP-CNTFwere TCA-precipitated, dissolved in
SDS sample buffer and loaded on a SDS-polyacrylamide gel (lanes 1+2). 50 ng of commercially available CNTF was loaded in lane 3. A, right panel: ACP-CNTF from transiently transfected
HeLa cells was concentrated from the medium and TCA-precipitated. Precipitates of supernatants (40–60 ng) or CNTF (75–100 ng) were dissolved and digested with PNGase F (+) or
without enzyme (−) for 20 h. SDS sample bufferwas addedand sampleswere analyzedwith SDS-PAGE/Western blotting. Bandswere visualizedusing speciﬁc antibodies: rabbit anti-CNTF,
anti-rabbit-HRP and the ECL system. (B) Labeling of ACP-CNTF. 60 ng of CNTF-ACP were labeled with 1–20 μM CoA-488 (dissolved in dimethyl sulfoxide) or incubated with dimethyl
sulfoxide only. SDS sample buffer was added and the samples were analyzed with SDS-PAGE and Western blotting. The membrane was scanned on a ﬂuorescence reader (Typhoon, GE
Healthcare) with a 526 SP Fluorescin, AlexaFluor 488 ﬁlter and a blue (488 nm) laser. Subsequently, membranes were blocked and proteins were detected with speciﬁc antibodies as
described above. (C) Expression and de-glycosylation of ACP-CNTFR. Left panel: HeLa cells were transiently transfected with CNTFRwt or ACP-CNTFR or mock-transfected (empty pCB6
vector). After 48h cellswere lysed, proteinsprecipitated andanalyzedwith SDS-PAGE/Western blotting. Rightpanel: StableMDCK-CNTFRwtorMDCK-ACP-CNTFRcellswere lysed, proteins
precipitatedwith acetoneanddissolved inSDS-buffer. SamplesweredigestedwithPNGaseF (+)or incubatedwithoutenzyme (−) for20hat37 °C.ACP-/CNTFRwasdetectedwithamouse
anti-CNTFR antibody, a speciﬁc secondary HRP-conjugated antibody and ECL. (D) Functionality of ACP-CNTF. Conﬂuent MDCK-CNTFR cells were stimulated with 25 ng/mL commercially
available CNTF or an equivalent amount of ACP-CNTF or left untreated (−) for 30 min at 37 °C. Cells were lysed and total proteinwas determined. Equal amounts of proteinwere analyzed
with SDS-PAGE/Western blotting. pY-STAT3 was detected with an activation-speciﬁc anti-pY705-STAT3 antibody from rabbit and anti-rabbit-HRP and ECL. Afterwards membranes were
incubated in a SDS/β-mercaptoethanol buffer at 50 °C for 30 min. To detect total STAT3, membranes were blocked again, and incubatedwith a rabbit anti-STAT3 antibody and a respective
secondary antibody. (E) Functionality of labeled ACP-CNTF and labeled ACP-CNTFR. HeLa cells were transiently transfected with CNTFRwt or ACP-CNTFR or left untransfected. As depicted
ACP-CNTFRwas labeled (+)with CoA-54748 h after transfection. As indicated cellswere stimulatedwith the respective unlabeled or CoA-488-labeledACP-CNTF (+) or left untreated (−)
for 30 min at 37 °C. Cells were lysed and equal amounts of protein were analyzed with SDS-PAGE and Western blotting. pY-STAT3/STAT3 were detected as described in D.
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For the colocalization studies of receptor and ligand, ACP-CNTFR
was labeled with CoA-488 dye and stimulated with ACP-CNTF thatwas labeled with CoA-647. As shown in Fig. 3, the ﬂuorescence of
CNTFR (Fig. 3A) and CNTF (Fig. 3B) located at the plasma membrane
clearly overlap after stimulation (Fig. 3C). For more than 95% of the
ACP-CNTF at least one ﬂuorescent receptor was present in the same
Fig. 2. Diffusion behavior of CNTFR and CNTF. (A) Normalized auto correlation function of
CoA-488 labeled ACP-CNTFR in HeLa cells (black squares). A two dimensional diffusion
model was used for the ﬁt (red line) to determine the diffusion constant of CNTFR at the
plasma membrane (D=2×10−9 cm2 s−1). (B) Normalized auto correlation function of
CoA-488 labeled ACP-CNTF in buffer solution (blue triangles) and after binding to the
CNTFR in HeLa cells (black squares). From the diffusion ﬁt (red line) we get the diffusion
constants D=7×10−7 cm2 s−1 for CNTF in solution and D=2×10−9 cm2 s−1 for CNTF
bound to CNTFR at the plasma membrane.
Fig. 3. Colocalization and cross correlation of CNTFR and CNTF at the plasma membrane. (A–
with CoA-488 (A), ACP-CNTF labeled with CoA-647 (B) and the merged image (C). Coloca
ﬂuorescent cytokine. (D) Normalized cross correlation function of CoA-647 labeled ACP-CN
dimensional diffusion model was used for the ﬁt (red line). The amplitude of the normalize
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colocalization [27] revealed that about 8% of the ﬂuorescent ACP-
CNTFR was bound to a ﬂuorescent cytokine. This observation was
independent of the CNTFR concentration at the plasma membrane.
In a next step we recorded the diffusion dynamics of ACP-CNTF
(CoA-647) and ACP-CNTFR (CoA-488) at the membrane simulta-
neously. We determined the fraction of co-migrating ligands and
receptors by cross correlation of the two components after stimulation
(CNTF binding). As shown in Fig. 3D, a signiﬁcant cross correlation
amplitude was observed. The amplitude of the cross correlation was
about 7.5% of the amplitude of the CNTFR auto correlation (see Fig.
2A).
The binding efﬁciency of two distinctly labeled partners (red CNTF
vs. green CNTFR) can be calculated by the ratio of the amplitudes of
cross and auto correlation. For a one-to-one binding of a green and a
red labeled protein this ratio is given by
Gx 0ð Þ=Gg 0ð Þ = c grð Þ = c rð Þ;Gx 0ð Þ=Gr 0ð Þ = c grð Þ = c gð Þ: ð1Þ
Thus, image colocalization analysis as well as FCCS evidently
showed that CNTF molecules were bound to CNTF receptors, and that
they subsequently diffused together.
3.4. Stoichiometry of the signaling complex — cross correlation of dual
color-labeled CNTFR or CNTF
We investigated the stoichiometry of the CNTF signaling complex
by FCCS using double labeling of one protein. For this, either the
CNTFR (Fig. 4) or CNTF (Fig. 5) was labeled with a 1:1 mixture of
ﬂuorophores CoA-488 and CoA-647. It can be anticipated that for a
signaling complex containing only one single CNTFR (tetrameric
model [14]) FCCS would not result in a signiﬁcant cross correlation
amplitude because the differently labeled receptors would then
diffuse independently. On the contrary, if the signaling complexC) Confocal scan image of two HeLa cells for colocalization analysis: ACP-CNTFR labeled
lization analysis [27] revealed that 8% of the ﬂuorescent ACP-CNTFR was bound to a
TF and CoA-488 labeled ACP-CNTFR after binding to HeLa cells (black squares). A two
d correlation function of 7.5% is equal to the fraction of CNTFR bound to a ligand.
Fig. 4. Dual color CNTFR cross correlation. (A) Normalized cross correlation function of
dual color (CoA-488 and CoA-647) labeled ACP-CNTFR before (blue triangles) and after
stimulation (black squares). A two dimensional diffusionmodel was used for the ﬁt (red
lines). No pre-association of the CNTFR was observable before stimulation; after
stimulation cross correlation of dual color CNTFR was observable, which indicates
complexes with at least two CNTFRs. (B) Histogram of ﬁtted relative amplitudes of cross
correlation function from measurements of dual color ACP-CNTFR before (black) and
after stimulation (red). The maximum of the distribution of the ﬁtted values before
stimulation is around 1% (not signiﬁcant for pre-association). After stimulation the
maximum of the distribution is around 4%. That indicates 8.5% of CNTFR in complexes
with at least two CNTFRs.
Fig. 5. Dual color CNTF cross correlation and FRET. Normalized correlation functions of
dual color (CoA-488 and CoA-647) ACP-CNTF at the plasmamembrane of HeLa cells. (A)
Normalized auto correlation of ACP-CNTF labeled with CoA-488. (B) Normalized cross
correlation of dual color CNTF. The relative amplitude of 7% indicates that 20–100% of
the CNTF molecules are part of complexes with at least two CNTFs. This estimation
depends on the FRET efﬁciency (see Supplementary data, Figs. A2 and A3). (C)
Normalized (to the amplitude of A) auto correlation of CoA-647 labeled ACP-CNTF due
to FRET excitation. Measured data are depicted as black squares, ﬁtted data using a two
dimensional diffusion model as a red line. The relative amplitude is comparable to the
amplitude of the cross correlation (B). Assuming a similar signal-to-noise ratio, this
indicates that all dual color pairs observed in cross correlation measurements show
FRET signal.
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higher-order model), this would be detectable by FCCS.
The ratio of cross correlation amplitude to auto correlation
amplitude is equal to the fraction of two-colored particles only for
the case of a one-to-one interaction of single-labeled monomers. In
general, the ratio of amplitudes of the cross correlation function to the
auto correlation function can be calculated as described previously
[33]. For a model containing two CNTF receptors per signaling
complex and assuming similar concentrations for CoA-488-labeled
CNTFR and CoA-647-labeled CNTFR, we get, under the further
assumption of a high signal-to-noise ratio and no FRET between the
ﬂuorophores, the ratio R
R = 0:5fdimerð Þ = 1 + 0:5fdimerð Þ ð2Þ
with fdimer, the fraction of CNTFRs forming a complex with two
CNTFRs (for a detailed description of Eq. (2) see Supplementary data).
Measurements of 180 s intervals were performed before and after
stimulation with non-ﬂuorescent CNTF to calculate the auto and cross
correlation functions. The diffusion constant was ﬁxed to the value
from the auto correlation ﬁt, and only the FCCS amplitude was ﬁtted
and related to the amplitude of the auto correlation function. FCCS
functions were ﬁtted from 1 to 200 ms to minimize the inﬂuence of
long term ﬂuctuations such as photo bleaching or spatial ﬂuctuations
of the membrane. The ratio of auto to cross correlation amplitude is
deﬁned as the relative amplitude. As expected for live cells, we found ahigh variance of the relative amplitudes. However, the histogram of all
ﬁtted relative amplitudes showed a signiﬁcant increase in the cross
correlation amplitudes after stimulation of cells with CNTF (Fig. 4B).
The maximum of the distribution of the relative amplitudes was
calculated to 4%. According to Eq. (2) this indicated that 8.5% of the
CNTFR were thus part of a signaling complex containing at least two
CNTFRs. Before stimulation the distribution of the calculated relative
cross correlation amplitudes had its maximum at 1% (Fig. 4A). As the
ﬁt algorithm always led to positive values for the amplitude, it was not
possible to distinguish between no cross correlation and a relatively
small cross correlation in the order of 1%. Thus, we concluded that
CNTFRs were not pre-associated prior to ligand binding.
In conclusion, FCCS analysis of dual color-labeled CNTF receptors
showed that after stimulation 8.5% of CNTFRs were part of complexes
with at least two CNTFRs. Comparing the amount of bound CNTF from
the previous experiment, we concluded that all stimulated CNTFRs
were part of such complexes.
When two CNTFRs are part of the CNTF receptor complex it should
also be possible to detect two CNTF molecules in such complexes. In
order to directly demonstrate this, ACP-CNTF was labeled with either
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cells that express the non-ﬂuorescent wild-type CNTFR. Analogous to
the CNTFR cross correlation measurements, we performed FCCS
experiments of 180 s duration (Fig. 5A, B). As for the CNTFR we can
detect FCCS with dual color-labeled ACP-CNTF. The variance of the
ﬁtted cross correlation amplitude was much smaller compared to
CNTFR cross correlation experiments. For these measurements, the
relative cross correlation amplitude was found to be 7%. When dual
color-labeled ACP-CNTF was measured in solution without cells no
cross correlation was detected (FCCS data not shown). Thus, we have
no evidence that ACP-CNTF already forms a dimer in solution. CNTF
dimers have been reported in the literature but they obviously only
form at high concentrations and it was proposed that they play a role
in CNTF storage within nerve cells [34].
3.5. FRET between dual color-labeled CNTF and CNTFR
Förster-type ﬂuorescence resonance energy transfer (FRET) is a
sensitive method to determine the distance between two ﬂuoro-
phores [35,36]. Suitable for distances in the order of a few nanometers,
FRET can be applied to monitor protein–protein interactions [37,38]
and their relative arrangements [39] or conformational changes [40]
even at the single molecule level [41,42]. To gather information of
distances between two labeled CNTFs or two CNTFRs within the
receptor complex, we excited only the CoA-488 labeled protein
directly with 488 nm and measured FRET by detecting the
ﬂuorescence of a nearby CoA-647. Instead of using the relative
ﬂuorescence intensities of the two ﬂuorophores or the ﬂuorescence
lifetime of the FRET donor ﬂuorophore, the amplitude of the auto
correlation function of the FRET acceptor ﬂuorophore was analyzed
according to Kohl et al. [43].
For dual color-labeled CNTFR no FRET signal was observed, neither
before nor after stimulation (data not shown). This indicated that
ACP-CNTFRs were arranged in the signaling complex in such a
geometry that the distance between the two ACP-tags exceeds
10 nm with and without bound CNTF.
In contrast, FRET was observed at the plasma membrane after
stimulation of CNTFR expressing cells with ACP-CNTF molecules
which were labeled with CoA-488 and CoA-647 in a 1:1 ratio (Fig. 5C).
We excited the CoA-488 labeled CNTFs directly with 5 μW continuous
wave laser excitation and detected the red ﬂuorescence from the FRET
acceptor. Even though a low signal-to-noise ratio of the FRET acceptor
does not allow us to quantify the rate of the energy transfer, the auto
correlation of the FRET-induced acceptor ﬂuorescence shows a
signiﬁcant amplitude. The amplitude of the FRET acceptor auto
correlation is 7% of the FRET donor auto correlation amplitude.
From the FCCS data of dual color-labeled ACP-CNTF (Fig. 5B) and
the observed FRET (Fig. 5C) we estimated that 20 to 100% of CNTFs are
part of complexes with at least two CNTFs. From the FRET measure-
ments we furthermore concluded that the distance between CoA-488
and CoA-647 is about 5 to 7 nm (for a detailed description of these
calculations see Supplementary data, Figs. A2 and A3).
4. Discussion
Hematopoietic cytokine signaling is a complex process especially
in those receptor systems that includemore than one receptor species.
Whereas erythropoietin and growth hormone only use one receptor
species, erythropoietin receptor and growth hormone receptor,
respectively, which upon dimerization [44] or dimer activation
[45,46] result in signal transduction, there are three receptor families
that employ two or even three different receptor chains, i.e. the
common γ-chain family, the common β-chain family and the gp130
family [47,48]. In each case, several cytokines elicit their speciﬁc
biological response by using a speciﬁc combination of promiscuous
receptor chains on target cells that express the appropriate receptorcombination. At least ten different IL-6-type cytokines are currently
known which use gp130 as a signal transducer [48,49]. Of these, IL-6
and IL-11 are the two cytokines that after binding to a speciﬁcα-chain
receptor lead to the recruitment of two gp130 molecules which is
sufﬁcient to activate cytoplasmatically attached janus kinases and to
recruit and activate STAT1 and 3 [50]. Most other IL-6-type cytokines
(CNTF, LIF, cardiotrophin-like cytokine (CLC) and cardiotrophin-1 (CT-
1)) recruit at least two signal transducers, gp130 and LIFR, whereas
OncostatinM (OSM) preferentially signals via the heterodimer gp130/
OSMR and IL-27 via gp130/IL-27R (WSX-1) respectively. CNTF, CLC
and CT-1 ﬁrst bind to a speciﬁc α-chain, the GPI-linked CNTFR, upon
which the two signal transducers are forming a complex that thus
consists of the ligand and three different receptor chains. Whereas the
identity of the receptor chains involved in the different cytokine
signaling complexes has been clariﬁed, there is still some ongoing
discussion concerning the exact stoichiometry of the receptor
components [8].
Early studies using recombinant IL-6 and the “soluble” extra-
cellular domains of the IL-6 receptor and gp130 in co-immunopre-
cipitation studies [10] and analytical ultracentrifugation [51] strongly
suggested that the IL-6 receptor complex is a hexamer containing
two IL-6, two IL-6R and two gp130. This notion was recently veriﬁed
by the elucidation of the crystal structure of the complex and single
particle electron microscopy [13]. In contrast, Pﬂanz et al. could
show that a nonsymmetrical IL-6/IL-6R/gp130 ternary complex is
capable of initiating the signal cascade. They propose a model of IL-
6-induced sequential engagement of IL-6R, gp130 and a second
gp130 [52].
A hexameric structure was also proposed for the related IL-11
receptor [53] and the CNTF receptor complex [11]. In the latter, one
gp130 in the hexamer is replaced by the LIFR. Although many of the
studies clearly favored the hexameric model for all of these complexes
[8], theoretical considerations also provided arguments that a
tetrameric complex containing only one ligand and one α-chain but
two signal transducers should be sufﬁcient for signaling to occur [54].
This possibility was recently supported by the ﬁnding that under
conditions where a hexameric IL-6 receptor complex is formed, a
tetrameric CNTFR complex was detected [14]. This quaternary
complex (CNTF, CNTFR, gp130 and LIFR) shows an asymmetric
structure which might also be a blueprint for the structure of the IL-
12 receptor complex.
A critical caveat of all studies published so far is the use of
recombinant proteins at supraphysiological concentrations and that
only in vitro studies were performed. In order to directly study the
receptor stoichiometry in living cells recently developed biophysical
techniques were employed which enable us to visualize single
receptor molecules in vivo. To this end, we created stable ﬂuorescently
labeled CNTF and CNTFR and followed their diffusion behavior by FCS/
FCCS and FRET. This is to our knowledge the ﬁrst time that FCS/FCCS
measurements were used to monitor cytokine and cytokine receptor
behavior in living cells.
Our major ﬁndings are: i) the GPI-linked CNTFR diffuses within the
plasma membrane with a diffusion constant similar to those of
transmembrane gp130 and LIFR; ii) CNTF in solution diffuses freely as
amonomer and upon interactionwith CNTFR expressing cells with the
same diffusion coefﬁcient as the CNTFR; iii) before ligation CNTF and
CNTFR are diffusing as single entities; iv) after ligation at least 8.5% of
detected CNTFRs and more than 20% of detected CNTF molecules are
migrating as dimers; and v) within formed receptor complexes, FRET
is detected between differently labeled CNTFs but not between
CNTFRs suggesting that the CNTF molecules are in closer proximity
than the CNTF receptors.
These ﬁndings are not consistent with a purely tetrameric nature
of the CNTF receptor complex but suggest that in living cells a
hexameric or even higher-order forms of this cytokine receptor
complex can be detected.
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were bound to labeled ACP-CNTF (Fig. 3). And this is under the
conditions in which a saturating amount of CNTF was added. Control
experiments (Fig. 1) had indicated that neither ACP-CNTFR nor ACP-
CNTF displays strongly reduced biological function. However, minor
alterations of bioactivity of these proteins cannot be excluded. We
currently also cannot exactly determine the labeling efﬁciency of ACP-
CNTF. For surface proteins a labeling efﬁciency of around 90% was
reported by the manufacturer. However, no data are available for
soluble proteins. Depending on the labeling efﬁciency of the ligand,
more or less colocalization with the receptor will be observed since
unlabeled CNTF bound to labeled receptors will give no signal.
Another possibility to explain the limited colocalization is that not
all of the labeled surface receptors are available for ligand binding since
theywere already endocytosed during the labeling period.Whether or
not CNTFRs are endocytosed in the absence of a ligand is currently
under investigation. Also, a limited availability of the high-afﬁnity
converters gp130 and LIF-R could be responsible for the low
colocalization observed. Indeed, by ﬂow cytometry we detected in
HeLa cells different expression rates for transfected ACP-CNTFR versus
endogenous LIFR and gp130 with ACP-CNTFR being the most widely
and strongly expressed protein (data are provided in Supplementary
data, Fig. A1). Whatever the reason and there may be several that add
up to the observed limitations, ourmeasurements clearly indicate that
at least about 10% and probably much more of surface CNTFRs are
employed in complexes that contain at least two molecules of CNTFR
and CNTF.
How does this ﬁnding relate to the observations of Skiniotis et al. of
a stable tetrameric complex formed in vitro [14]? One possibility is
that the different natures of the studied systems (in vitro versus in
vivo) are responsible for the discrepancy. Another hypothesis could be
that two different kinds of receptor complexes form at the plasma
membrane: tetramers as well as hexamers. If this turns out to be the
case, one can only speculate why two different complexes may exist
and which – if not both – are relevant for signaling.
There is still another possibility and it is the one we are currently
favoring since it reconciles our ﬁndings with those of Skiniotis et al.
Maybe what we detected were not hexamers as classically proposedFig. 6. Hypothetical models of a hexameric and an octameric CNTF receptor complex. Model
upper panel (A) shows the possible association of a second CNTF/CNTFR with the CNTF/CN
the dimerization of two tetramers via a gp130/gp130 interaction resulting in an octamericbut dimers of tetramers, i.e. octamers. Two arguments can be put
forward to support this hypothesis. Firstly, in a study addressing the
issue of pre-association of gp130 homodimers or gp130/LIFR hetero-
dimers Giese et al. recently demonstrated by FRET and bimolecular
ﬂuorescence complementation [55] that gp130 homodimers partially
already form in the absence of a ligand, whereas gp130/LIFR
heterodimers only form after ligand engagement. Thus, the possibility
arises that a preformed gp130 homodimer is recruiting two CNTF/
CNTFR complexes and two LIFRs resulting in an octameric complex in
which all subunits are doubly present. It is currently not clear what
drives the dimerization of unligated gp130. However, since this was
not observed with recombinant extracellular domains of the signal
transducer either the transmembrane domain and/or the intracellular
domain may be responsible for this interaction. Such an interaction
would only be detectable in cells and would thus have escaped the
assays of Skiniotis et al. and others. Secondly, the existence of such
hematopoietic receptor “super” complexes has recently elegantly
been demonstrated by Hansen et al. [56]. Upon studying the structure
of the related common βc-family member granulocyte-macrophage-
colony-stimulating factor receptor complex – until recently believed
to be a hexamer – they came up with a model that the active signaling
complex is a dodecamer consisting of two hexamers aligning via an
interaction of two βc-chains. Mutation of critical residues in the
interface between the two hexamers affects signaling suggesting that
the formation of dodecamers is crucial for signaling to occur. We
propose that a similar interaction of two gp130 signal transducers
might result in the formation of an octameric receptor complex when
CNTF is binding ﬁrst to its receptor and then recruits gp130 and LIFR
(Fig. 6).
Whether the formation of such an octamer would be necessary for
signaling to occur can currently not be answered. One feature of our
model will be addressed in the near future by FCCS, namely whether
two differently labeled LIFRs will colocalize after formation of a CNTF
receptor complex. Since GFP variants of cytokine receptors in our
hands are not helpful in this respect, LIFR molecules with ACP- or
related tags will be necessary to address this problem.
In conclusion, our study suggests that the formation of a simple
tetramer is not thewhole story for the CNTF receptor complex but thats were drawn according to the tetrameric structure proposed by Skiniotis et al. [14]. The
TFR/gp130/LIFR tetramer resulting in a hexameric complex; the lower panel (B) shows
stoichiometry. CNTF, red; CNTFR, green; gp130, blue; LIFR, rose.
1899F. Neugart et al. / Biochimica et Biophysica Acta 1788 (2009) 1890–1900other structures, either a hexamer or maybe more likely a dimer of
tetramers, i.e. an octamer, might form at the plasma membrane of
living cells.
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